Singh, Sunil Kumar

Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration. [electronic resource] - Bioorganic & medicinal chemistry Dec 2006 - 8626-34 p. digital

Publication Type: Journal Article

0968-0896

10.1016/j.bmc.2006.08.024 doi


Administration, Oral
Animals
Benzothiazoles--administration & dosage
Carrageenan--toxicity
Cyclooxygenase 1--chemistry
Cyclooxygenase 2--chemistry
Cyclooxygenase 2 Inhibitors--administration & dosage
Edema--chemically induced
Endotoxins--toxicity
Enzyme Inhibitors--administration & dosage
Fever--chemically induced
Foot
Humans
Hyperalgesia--chemically induced
Injections, Spinal
Male
Microsomes--enzymology
Molecular Structure
Prodrugs--administration & dosage
Rats
Rats, Wistar
Seminal Vesicles--enzymology
Solubility
Structure-Activity Relationship
Sulfonamides--administration & dosage